Overexpression of mitochondrial uncoupling protein 2 inhibits inflammatory cytokines and activates cell survival factors after cerebral ischemia

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Haines, Bryan ^a   Li, P Andy ^b  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CYTOKINE; HEAT SHOCK PROTEIN 90; HISTONE ACETYLTRANSFERASE PCAF; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN P300; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 2; APOPTOSIS REGULATORY PROTEIN; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B CELL LEUKEMIA LYMPHOMA 2 GENE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CHECKPOINT KINASE 1 HOMOLOG GENE; CONTROLLED STUDY; CYCLIN G2 GENE; CYCLIN H GENE; ESTROGEN RECEPTOR 1 ALPHA GENE; GENE EXPRESSION; INNATE IMMUNITY; INTERLEUKIN 6 GENE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; MYELOCYTOMATOSIS ONCOGENE; MYELOID CELL LUKEMIA SEQUENCE 1 GENE; NEUROPROTECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR NECROSIS FACTOR GENE; UPREGULATION; V CELL RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG A; ANIMAL; CELL CYCLE; CELL SURVIVAL; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSIENT ISCHEMIC ATTACK;

MUS;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRAIN ISCHEMIA; CELL CYCLE; CELL SURVIVAL; CYTOKINES; GENE EXPRESSION REGULATION; INFLAMMATION; ION CHANNELS; ISCHEMIC ATTACK, TRANSIENT; MICE; MITOCHONDRIAL PROTEINS; NEUROPROTECTIVE AGENTS;

EID: 84856894586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031739     Document Type: Article

References (53)

1. Iijima T, Mishima T, Akagawa K, Iwao Y, (2003) Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res 993: 140-145.
2. Ouyang YB, Xu LJ, Sun YJ, Giffard RG, (2006) Overexpression of inducible heat shock protein 70 and its mutants in astrocytes is associated with maintenance of mitochondrial physiology during glucose deprivation stress. Cell Stress Chaperones 11: 180-186.
3. Choi K, Kim J, Kim GW, Choi C, (2009) Oxidative stress-induced necrotic cell death via mitochondira-dependent burst of reactive oxygen species. Curr Neurovasc Res 6: 213-222.
4. Nicholls DG, Bernson VS, (1977) Inter-relationships between proton electrochemical gradient, adenine-nucleotide phosphorylation potential and respiration, during substrate-level and oxidative phosphorylation by mitochondria from brown adipose tissue of cold-adapted guinea-pigs. Eur J Biochem 75: 601-612.
5. Mehta SL, Li PA, (2009) Neuroprotective role of mitochondrial uncoupling protein 2 in cerebral stroke. J Cereb Blood Flow Metab 29: 1069-1078.
6. Teshima Y, Akao M, Jones SP, Marban E, (2003) Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 93: 192-200.
7. Yoshitomi H, Yamazaki K, Tanaka I, (1999) Mechanism of ubiquitous expression of mouse uncoupling protein 2 mRNA: control by cis-acting DNA element in 5′-flanking region. Biochem J 340: 397-404.
8. Lengacher S, Magistretti PJ, Pellerin L, (2004) Quantitative rt-PCR analysis of uncoupling protein isoforms in mouse brain cortex: methodological optimization and comparison of expression with brown adipose tissue and skeletal muscle. J Cereb Blood Flow Metab 24: 780-788.
9. Jezek P, (2002) Possible physiological roles of mitochondrial uncoupling proteins-UCPn. Int J Biochem Cell Biol 34: 1190-1206.
10. Bechmann I, Diano S, Warden CH, Bartfai T, Nitsch R, et al. (2002) Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury. Biochem Pharmacol 64: 363-367.
11. Kim HS, Park KG, Koo TB, Huh S, Lee IK, (2007) The modulating effects of the overexpression of uncoupling protein 2 on the formation of reactive oxygen species in vascular cells. Diabetes Res Clin Pract 77 (Suppl 1): S46-48.
12. Mattiasson G, Shamloo M, Gido G, Mathi K, Tomasevic G, et al. (2003) Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med 9: 1062-1068.
13. Nakase T, Yoshida Y, Nagata K, (2007) Amplified expression of uncoupling proteins in human brain ischemic lesions. Neuropathology 27: 442-447.
14. Liu Y, Chen L, Xu X, Vicaut E, Sercombe R, (2009) Both ischemic preconditioning and ghrelin administration protect hippocampus from ischemia/reperfusion and upregulate uncoupling protein-2. BMC Physiol 9: 17.
15. Zhao H, (2009) Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab 29: 873-885.
16. Yano S, Morioka M, Fukunaga K, Kawano T, Hara T, et al. (2001) Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab 21: 351-360.
17. Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, et al. (2005) Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 25: 9794-9806.
18. Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, et al. (2008) In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J Cereb Blood Flow Metab 28: 232-241.
19. Sawe N, Steinberg G, Zhao H, (2008) Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res 86: 1659-1669.
20. Chan PH, (1996) Role of oxidants in ischemic brain damage. Stroke 27: 1124-1129.
21. Minami M, Katayama T, Satoh M, (2006) Brain cytokines and chemokines: roles in ischemic injury and pain. J Pharmacol Sci 100: 461-470.
22. Sriram K, O'Callaghan JP, (2007) Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol 2: 140-153.
23. Shohami E, Ginis I, Hallenbeck JM, (1999) Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev 10: 119-130.
24. Horvath TL, Diano S, Miyamoto S, Barry S, Gatti S, et al. (2003) Uncoupling proteins-2 and 3 influence obesity and inflammation in transgenic mice. Int J Obes Relat Metab Disord 27: 433-442.
25. Li PA, Gisselsson L, Keuker J, Vogel J, Smith ML, et al. (1998) Hyperglycemia-exaggerated ischemic brain damage following 30 min of middle cerebral artery occlusion is not due to capillary obstruction. Brain Res 804: 36-44.
26. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, et al. (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472-476.
27. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, et al. (2003) Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34: 1864-1869.
28. Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G, (2008) Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 14: 3574-3589.
29. Ishibashi N, Prokopenko O, Reuhl KR, Mirochnitchenko O, (2002) Inflammatory response and glutathione peroxidase in a model of stroke. J Immunol 168: 1926-1933.
30. Rousset S, Emre Y, Join-Lambert O, Hurtaud C, Ricquier D, et al. (2006) The uncoupling protein 2 modulates the cytokine balance in innate immunity. Cytokine 35: 135-142.
31. Fiskum G, Rosenthal RE, Vereczki V, Martin E, Hoffman GE, et al. (2004) Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J Bioenerg Biomembr 36: 347-352.
32. Ouyang YB, Giffard RG, (2004) Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium 36: 303-311.
33. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, et al. (1994) Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13: 1017-1030.
34. Liu XQ, Sheng R, Qin ZH, (2009) The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin 30: 1071-1080.
35. Lu D, Jiang D, (1997) [The expression of hsp70 and BCL-2 genes in hippocampus of the rats exposed to cerebral ischemia and reperfusion]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 13: 224-227.
36. Craig RW, (2002) MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 16: 444-454.
37. Mori M, Burgess DL, Gefrides LA, Foreman PJ, Opferman JT, et al. (2004) Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons. Cell Death Differ 11: 1223-1233.
38. Chung H, Kim E, Lee DH, Seo S, Ju S, et al. (2007) Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 148: 148-159.
39. Li Y, Chopp M, Powers C, Jiang N, (1997) Immunoreactivity of cyclin D1/cdk4 in neurons and oligodendrocytes after focal cerebral ischemia in rat. J Cereb Blood Flow Metab 17: 846-856.
40. Gao Q, Zhou J, Huang X, Chen G, Ye F, et al. (2006) Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus. Mol Ther 13: 928-937.
41. Elzer JG, Muhammad S, Wintermantel TM, Regnier-Vigouroux A, Ludwig J, et al. Neuronal estrogen receptor-[alpha] mediates neuroprotection by 17[beta]-estradiol. J Cereb Blood Flow Metab 30: 935-942.
42. Nakagomi T, Asai A, Kanemitsu H, Narita K, Kuchino Y, et al. (1996) Up-regulation of c-myc gene expression following focal ischemia in the rat brain. Neurol Res 18: 559-563.
43. Macdonald K, Bennett MR, (1999) cdc25A is necessary but not sufficient for optimal c-myc-induced apoptosis and cell proliferation of vascular smooth muscle cells. Circ Res 84: 820-830.
44. Palgrave CJ, Gilmoour L, Lowden CS, Lillico SG, Mellencamp MA, et al. (2011) Species-specific variation in RELA underlies differences in NF-κB activity: a potential role in African swine fever pathogenesis. J Virol 85: 6008-6014.
45. Dhodda VK, Sailor KA, Bowen KK, Vemuganti R, (2004) Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 89: 73-89.
46. Clark CB, Rane MJ, El Mehdi D, Miller CJ, Sachleben LR Jr, et al. (2009) Role of oxidative stress in geldanamycin-induced cytotoxicity and disruption of Hsp90 signaling complex. Free Radic Biol Med 47: 1440-1449.
47. Ginsberg MD, Sternau LL, Globus MY, Dietrich WD, Busto R, (1992) Therapeutic modulation of brain temperature: relevance to ischemic brain injury. Cerebrovasc Brain Metab Rev 4: 189-225.
48. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, et al. (1996) An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A 93: 12969-12973.
49. Kaya D, Gursoy-Ozdemir Y, Yemisci M, Tuncer N, Aktan S, et al. (2005) VEGF protects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. J Cereb Blood Flow Metab 25: 1111-1118.
50. Dang S, Liu X, Fu P, Gong W, Fan F, et al. (2011) Neuroprotection by local intra-arterial infusion of erythropoietin after focal cerebral ischemia in rats. Neurol Res 33: 520-528.
51. Ding XL, Husseman J, Tomashevski A, Nochlin D, Jin LW, et al. (2000) The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. Am J Pathol 157: 1983-1990.
52. Bernardi R, Liebermann DA, Hoffman B, (2000) Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation. Oncogene 19: 2447-2454.
53. Macdonald K, Bennett MR, (1999) cdc25A is necessary but not sufficient for optimal c-myc-induced apoptosis and cell proliferation of vascular smooth muscle cells. Circ Res 84: 820-830.